Conference Correspondent

mCRC Daily News from ASCO 2014: May 30, 2014 - Preview of Key Topics

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — May 31, 2014

Immuno-Oncology: The New Frontier?

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Ipilimumab Combined with Cytotoxic Chemotherapy in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Doublets and Triple Combinations in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Stereotactic Radiosurgery and Ipilimumab for Melanoma Brain Metastases

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Peginterferon alfa-2b Combined with Ipilimumab for Advanced Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Single-Agent Nivolumab in Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Nivolumab Combined with Platinum-Based Doublet Chemotherapy in Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — May 31, 2014

Next-Generation TKIs

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Value-Based Use of Molecular and Genomic Markers

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Page 42 of 44

39
40
41
42
43
44